Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases
Clinical trial NCT03732482 · UNKNOWN
Trial details
- NCT number
- NCT03732482
- Sponsor
- Taizhou Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-01-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.